Similar articles

• BCG as active immunotherapy in children with acute lymphoblastic leukemia in longstanding remission: positive effects on remission duration and immunologic parameters.

  Miale TD, Yocum D, Yocum C. Miale TD, et al. Biomedicine. 1978 May;28(2):96-104. Biomedicine. 1978. PMID: 276382
• [BCG and irradiated allogenic blast cells in maintenance chemotherapy of children with acute lymphoblastic leukemia in remission. A controlled study].

  Ortega JJ, Javier G. Ortega JJ, et al. Sangre (Barc). 1982;27(3):349-57. Sangre (Barc). 1982. PMID: 6760428 Clinical Trial. Spanish. No abstract available.
• [Cellular immunity in children with acute lymphoblastic leukemia].

  Gebauer E, Stanković G, Krstić A. Gebauer E, et al. Med Pregl. 1980;33(9-10):387-90. Med Pregl. 1980. PMID: 6936608 Croatian. No abstract available.
• Immunotherapy in acute leukemias. Possible applications in children.

  Mahoney DH Jr, Starling KA. Mahoney DH Jr, et al. Am J Pediatr Hematol Oncol. 1981 Winter;3(4):410-8. Am J Pediatr Hematol Oncol. 1981. PMID: 7036781 Review.
• Immunological aspects of acute leukemia in man.

  Piessens WF, Moloney WC. Piessens WF, et al. Eur J Cancer (1965). 1976 Jul;12(7):511-7. doi: 10.1016/0014-2964(76)90156-0. Eur J Cancer (1965). 1976. PMID: 782891 Review. No abstract available.